BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 12882387)

  • 1. New advances transform the management of women with abnormal pap tests.
    Jin XW; Nielsen C; Brainard J; Yen-Lieberman B
    Cleve Clin J Med; 2003 Jul; 70(7):641-8. PubMed ID: 12882387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the system of Papanicolaou test nomenclature affect the rate of referral for colposcopy? A survey of family physicians.
    Melnikow J; Sierk A; Flocke S; Peters CA
    Arch Fam Med; 1993 Mar; 2(3):253-8. PubMed ID: 8252144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cervical cytology: new names, familiar smears.
    Carulli DT
    J Am Acad Nurse Pract; 2003 Oct; 15(10):444-9. PubMed ID: 14606133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry?
    Baer A; Kiviat NB; Kulasingam S; Mao C; Kuypers J; Koutsky LA
    Obstet Gynecol; 2002 Jun; 99(6):1053-9. PubMed ID: 12052599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing human papillomavirus of the female lower genital tract: failure of the Pap smear as a sole screening test.
    Lonky NM; Mahoney A; Sauer MV
    J Gynecol Surg; 1991; 7(3):183-9. PubMed ID: 10150073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear.
    Vassilakos P; de Marval F; Muñoz M; Broquet G; Campana A
    Int J Gynaecol Obstet; 1998 Apr; 61(1):45-50. PubMed ID: 9622172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cervical cancer. Current terminology, classification, and technique.
    Fowler J
    Postgrad Med; 1993 Feb; 93(2):57-64, 70. PubMed ID: 8381956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study].
    Kahng J; Lee HJ
    Korean J Lab Med; 2008 Feb; 28(1):70-8. PubMed ID: 18309258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ASC-US Pap Smear follow-up in a French department in 2077].
    Giuria C; Guiheneuc E; Coimet F; Caillez E; Baron C
    Sante Publique; 2015; 27(5):659-67. PubMed ID: 26752032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papanicolaou smear: an update on classification and management.
    Fullerton JT; Barger MK
    J Am Acad Nurse Pract; 1989; 1(3):84-90. PubMed ID: 2631935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap smears and screening for cervical neoplasia.
    Wilkinson EJ
    Clin Obstet Gynecol; 1990 Dec; 33(4):817-25. PubMed ID: 2289348
    [No Abstract]   [Full Text] [Related]  

  • 12. Updates in Cervical Cytology: The 90-Year-Long Journey from Battle Creek to Today.
    Roe CJ; Hanley KZ
    Surg Pathol Clin; 2018 Sep; 11(3):589-599. PubMed ID: 30190142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of simultaneous cervical cytology, HPV testing, and colposcopy.
    Hockstad RL
    Fam Pract Res J; 1992 Mar; 12(1):53-60. PubMed ID: 1312758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual colposcopies and pap smears recommended for women with HIV.
    Highleyman L
    BETA; 1999 Apr; 12(2):6. PubMed ID: 11366700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formal proposal to combine the Papanicolaou Numerical System with Bethesda terminology for reporting cervical/vaginal cytologic diagnoses.
    Frankel K
    Diagn Cytopathol; 1994; 10(4):395-6. PubMed ID: 7924818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.